Affinity Asset Advisors, LLC Ocular Therapeutix, Inc Transaction History

Affinity Asset Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$6.16 - $12.07 $4.62 Million - $9.05 Million	-750,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $4.85 Million - $7.17 Million	500,000 Added 200.0%	750,000 $7.5 Million
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $302,175 - $431,100	22,500 Added 9.89%	250,000 $3.55 Million
Q1 2021 May 14, 2021	BUY	$15.82 - $22.11 $118,650 - $165,825	7,500 Added 3.41%	227,500 $3.73 Million
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $1.74 Million - $5.05 Million	220,000 New	220,000 $4.55 Million

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $659M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.